Factor Xa Inhibitor Versus Standard of Care Heparin in Hospitalized Patients With COVID-19 (XACT)

NCT04640181 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Covid19

Interventions

DRUG: Enoxaparin
DRUG: Rivaroxaban

Sponsor

St. David's HealthCare